What Is Chondral Loss? Causes, Symptoms, and Treatments

Understand chondral loss: the degradation of joint cartilage. Learn its implications for joint function and how it’s diagnosed and managed.

Chondral loss is the wearing away or destruction of articular cartilage, the smooth, rubbery tissue that coats the ends of bones inside a joint and allows them to glide against each other without friction. It can range from mild surface softening to full-thickness erosion that exposes bare bone, and unlike a broken bone or a cut on your skin, damaged cartilage has very little ability to repair itself. The condition affects knees most commonly, but it shows up in hips, ankles, and shoulders too, and it sits at the center of why osteoarthritis hurts and why sports injuries sometimes have consequences that last far longer than the injury itself.

Why Cartilage Cannot Fix Itself

Most tissues in your body have a built-in repair crew. Blood vessels deliver oxygen and immune cells, nerves signal that something is wrong, and new cells migrate in to patch things up. Articular cartilage has almost none of that infrastructure. It contains no blood vessels, no nerves, and no lymphatic drainage; it gets its nutrients passively from the thin layer of synovial fluid that bathes the joint. The cells that live inside cartilage, called chondrocytes, are sparse and relatively inactive in adults. When cartilage is damaged, those few cells cannot multiply fast enough or produce enough new matrix to fill the gap. A shallow scratch in the surface may never progress, but it also may never heal.

This limited repair capacity is the central frustration of chondral loss. A meniscus tear or a ligament rupture, while serious, occurs in tissue that has a blood supply and at least some regenerative potential. Cartilage damage, even when it is smaller or seemingly less dramatic, can be far more permanent. That biological reality shapes every treatment decision, from initial rehab to whether surgery makes sense.

How Cartilage Breaks Down

At the cellular level, chondral loss involves a cascade of destructive processes. Inflammatory molecules, enzymes that chew through the cartilage matrix, and the byproducts of that breakdown itself all contribute to a vicious cycle. Research has shown that once excessive breakdown begins, the degradation products themselves can drive further cartilage destruction, creating a self-amplifying loop. At the same time, chondrocyte death accelerates in zones where the cartilage is already damaged and where mechanical loading is highest. In plain terms, the more damaged the cartilage gets, the faster it tends to worsen, which is why early recognition matters.

Common Causes

Chondral loss is not a single disease with a single trigger. It sits at the intersection of mechanical forces, biological vulnerability, and time. The main drivers overlap and reinforce each other.

  • Acute injury: A hard blow to the joint, a sudden twist, or a sports collision can shear cartilage off the bone surface. These traumatic defects are especially common in younger, active people and are frequently discovered during knee arthroscopy. The majority of patients undergoing routine knee arthroscopy show evidence of at least some chondral damage, ranging from small asymptomatic spots to large, disabling defects.
  • Joint malalignment and instability: If your knee tracks slightly crooked due to bowed legs, knocked knees, or a torn ligament, abnormal loading concentrates force on one part of the cartilage. Over months and years, that overloaded patch wears thin. The combination of malalignment, ligament laxity, and existing meniscal or chondral damage is particularly difficult to manage because each problem makes the others worse.
  • Obesity and metabolic dysfunction: Excess weight increases the mechanical load on weight-bearing joints, but that is only half the story. Current evidence points to impaired chondrocyte metabolism and immune-system dysregulation as additional pathways connecting obesity to cartilage breakdown, meaning the problem is partly biochemical, not just mechanical.
  • Age and chronic overuse: Decades of loading and micro-trauma accumulate. Cartilage gradually thins, loses water content, and becomes stiffer and more brittle. This process is a normal part of aging, but it accelerates in joints that were previously injured or that bear disproportionate load.

An anterior cruciate ligament (ACL) tear deserves special mention as a risk accelerator. Research using cartilage biomarkers has found that significant cartilage damage can already be present shortly after an ACL injury, even before standard X-rays pick up any changes. That early, invisible damage helps explain why so many people with a history of ACL tears develop arthritis in the affected knee years later.

What It Feels Like

Because cartilage has no nerves, the cartilage loss itself is painless. What hurts is everything downstream. When the protective surface wears through, the underlying bone, the joint lining, and the surrounding soft tissues all become irritated. The result is a cluster of symptoms that can range from mildly annoying to genuinely disabling.

Deep, achy joint pain that worsens with activity and eases with rest is the most common complaint. Swelling after exercise or prolonged standing is typical. Many people notice stiffness after sitting for a while, sometimes accompanied by a grating or catching sensation during movement. In more advanced cases, the joint may lock briefly or give way without warning. The tricky part is that these symptoms overlap almost entirely with meniscus tears, early osteoarthritis, and other internal joint problems, so symptoms alone cannot confirm the diagnosis.

How Chondral Loss Is Diagnosed

A physical exam can raise suspicion, but imaging is where the real answers come from. Standard X-rays show bone and joint space narrowing but reveal nothing about the cartilage surface itself. MRI is the primary noninvasive tool for evaluating cartilage. Advances in MRI techniques have greatly improved the ability to detect early cartilage changes, including subtle softening and thinning, before visible cracks or erosions develop.

When surgery is being considered, arthroscopy provides the most direct look. The surgeon can see and probe the cartilage surface in real time, assess depth and size, and grade the damage. Two widely used grading systems, the Outerbridge and the ICRS classifications, divide cartilage lesions into stages from softening (grade I) to full-thickness loss exposing bone (grade IV). Both systems are imperfect, though. When multiple surgeons independently graded the same cartilage lesions on video, agreement between them was only moderate at best, which means two experienced doctors can look at the same defect and assign different grades. That inconsistency matters because the chosen grade often influences treatment decisions.

Conservative Treatment

Not every chondral defect requires surgery. For many people, especially those with smaller lesions or lower activity demands, a combination of non-surgical strategies can manage symptoms effectively and slow further deterioration.

Physical Therapy and Activity Modification

Rehabilitation for chondral lesions focuses on restoring full, pain-free range of motion, building muscle strength around the joint, and improving the body’s proprioceptive control, your ability to sense and adjust joint position. The goal is to reduce pain and improve function without accelerating the cartilage damage that already exists. Low-impact activities like cycling, swimming, and elliptical training tend to be better tolerated than running or jumping. Strengthening the quadriceps and hamstrings takes some of the mechanical stress off the cartilage, which can meaningfully reduce pain even when the cartilage defect itself hasn’t changed.

Unloader Bracing

An unloader brace is designed to shift the load away from the damaged compartment of the knee. An international expert consensus study found that unloader bracing is a biomechanically sound and clinically useful tool for patients with cartilage lesions in the tibiofemoral joint, particularly when there is malalignment or neutral alignment on the affected side. The experts endorsed its use in both non-surgical management and as a complement during rehabilitation after cartilage repair procedures. In one randomized trial, patients who wore an unloader brace after microfracture surgery showed greater cartilage repair tissue volume and thickness than those who went without a brace, and wearing the brace more consistently correlated with better symptom and quality-of-life scores.

Injections

Platelet-rich plasma (PRP), drawn from your own blood and concentrated, has emerged as a popular injection therapy for cartilage-related joint pain. The idea is that growth factors in concentrated platelets promote tissue healing and reduce inflammation. A narrative review found evidence that PRP can promote articular cartilage recovery and improve pain scores, particularly when combined with hyaluronic acid (HA). A systematic review and meta-analysis of the PRP-plus-HA combination found that it reduced knee pain more than PRP alone at six months and improved function scores at twelve months, with no increase in side effects.

Results are less clear-cut in the hip. A randomized controlled trial of hip osteoarthritis found that PRP alone produced the lowest pain scores at six months, actually outperforming the PRP-plus-HA combination in that joint. The takeaway is that injection therapies are not one-size-fits-all; results seem to depend on which joint is treated, the severity of disease, and the specific formulation used.

Surgical Options

When conservative measures fail and pain or functional limitations persist, surgery aims to either stimulate new cartilage growth, transplant healthy cartilage into the defect, or replace the damaged joint surface. The choice depends on defect size, location, the patient’s age and activity level, and what other joint problems coexist.

Microfracture

Microfracture is the most commonly performed surgical technique for chondral defects in the knee. The surgeon makes tiny holes through the exposed bone to allow marrow elements, including stem cells, to seep into the defect and form a clot that eventually matures into repair tissue. The catch is that this repair tissue is fibrocartilage, a tougher but less smooth and less durable tissue than the original hyaline cartilage. Microfracture works well for smaller defects and can buy years of improved function, but the fibrocartilage fill tends to deteriorate over time, especially in larger lesions or in patients who return to high-impact activity.

Osteochondral Autograft and Allograft Transfer

For focal cartilage defects on the femoral condyles, a surgeon can transplant a plug of healthy cartilage and underlying bone from a less weight-bearing area of the same knee (autograft) or from a donor (allograft). The advantage is that the transplanted surface is genuine hyaline cartilage, which is mechanically superior to the fibrocartilage produced by microfracture. A systematic review and meta-analysis found that both autografts and allografts produce favorable patient-reported outcomes and good graft survival at medium-term follow-up, though proper patient selection remains critical to long-term success. Autografts are limited by the amount of healthy cartilage you can safely harvest without creating a new problem at the donor site. Allografts solve that size limitation but introduce concerns about graft availability and disease transmission.

Matrix-Induced Autologous Chondrocyte Implantation (MACI)

MACI is a two-stage procedure. In the first operation, a small sample of healthy cartilage is harvested and sent to a lab, where the chondrocytes are grown on a collagen membrane. In the second surgery, that cell-seeded membrane is implanted into the defect. The result is tissue closer to native hyaline cartilage than what microfracture produces. A randomized trial comparing MACI to microfracture in patients with defects between four and ten square centimeters found that MACI produced significantly better functional scores over two years. Longer-term data is encouraging as well: a systematic review of studies with at least ten years of follow-up found that MACI patients maintained significant improvements in patient-reported outcomes, showed satisfactory defect fill on MRI, and had low rates of reoperation or eventual knee replacement.

MACI’s downsides are cost, the need for two surgeries, and a prolonged rehabilitation period. It tends to be reserved for younger, active patients with larger defects who are not good candidates for simpler procedures.

Partial and Total Joint Replacement

When cartilage loss is extensive and concentrated in one part of the knee, partial knee replacement (unicompartmental arthroplasty) can resurface just the damaged compartment while preserving the rest. This option bridges the gap between cartilage restoration procedures and full joint replacement. Importantly, outcomes are better when the cartilage loss in the treated compartment is full-thickness rather than partial. A meta-analysis found that patients with full-thickness loss had superior post-operative scores and lower reoperation rates after unicompartmental arthroplasty than those with only partial-thickness damage, suggesting the procedure is best suited to end-stage disease in a single compartment.

A study examining cartilage loss patterns in patients with end-stage knee osteoarthritis found that roughly two-thirds had damage patterns that could be addressed with some form of partial rather than total knee replacement, including unicompartmental or bicompartmental options. Total knee replacement remains the definitive solution when multiple compartments are involved or when the joint is too far gone for partial measures.

Rehabilitation After Cartilage Surgery

No matter which surgical technique is used, the postoperative rehabilitation period is long compared to many other orthopedic procedures. Protocols generally emphasize early protected motion, often using a continuous passive motion machine, gradual weight-bearing progression, and a structured strengthening program. Bracing is commonly used in the early recovery phase. Protocols are not standardized across centers, but recent evidence suggests that accelerated rehabilitation after MACI may actually produce better outcomes than the traditional slower approach.

Return to sport timelines vary widely. Microfracture patients may begin light sports around four to six months, while MACI and osteochondral transplant patients often need nine months to a year or more before high-impact activities are safe. Managing expectations is important: returning to some level of sport is realistic for most patients, but returning to the exact same intensity and volume as before the injury is not guaranteed.

Chondral Loss in Children and Adolescents

Young patients have a biological advantage. Compared to adults, children and adolescents have a greater capacity to regenerate cartilage defects, likely because their chondrocytes are more active and their subchondral bone is still growing. Even so, cartilage injuries in young people should not be dismissed. Left untreated, they can predispose the joint to premature osteoarthritis. When surgery is needed, extra attention must be given to the subchondral bone, which is more frequently involved in the pediatric population than in adults. The stakes are high because a fifteen-year-old has many more decades of joint use ahead, and an early cartilage defect that progresses can mean living with arthritis in your thirties or forties.

Why Animal Research Does Not Always Translate

If you have read about cartilage repair breakthroughs in preclinical studies and wondered why they have not reached your doctor’s office yet, part of the answer lies in how differently cartilage behaves across species. Small animals like rabbits and rodents have thin cartilage and a much greater intrinsic healing capacity than humans, which means a treatment that works in a rabbit knee may fail in a human one. Researchers have noted that only equine models, with their thicker cartilage and defect sizes comparable to clinically significant human lesions, reliably replicate the challenge of human cartilage repair. This is one of the reasons the gap between laboratory success and clinical reality remains wider in cartilage science than in many other areas of orthopedics.

Emerging Research in Cartilage Tissue Engineering

The most ambitious frontier in treating chondral loss is growing replacement cartilage from scratch. Over the past two decades, 3D bioprinting using hydrogel-based scaffolds has significantly advanced cartilage and bone tissue engineering. The idea is to print a scaffold that mimics the layered architecture of native cartilage, seed it with cells or growth factors, and implant it into the defect. Researchers are working on bioinks that can reproduce the zonal stratification of real cartilage, since the tissue’s top, middle, and deep layers have different compositions and mechanical properties. These approaches are still in the laboratory and early-trial phase, but they represent the closest thing to a true cartilage replacement rather than a workaround. Whether they will mature into widely available clinical treatments in the next decade remains an open question, but the pace of progress over the past few years has been faster than many in the field expected.